chrisvoncsefalvay/vaers-outcomes huggingface dataset:
January 9, 2023, I started having a cough and sore throat, I went to an urgent care where I was tested for COVID-19, Influenza A and B, and RSV all tests came back negative, I was given a prescription for benzonatate and told me to continue, taking MUCINEX. Seven days later I developed a high-grade fever and went back to the urgent care and was retested for COVID-19, Influenza A and B, RSV and did a chest x-ray. All came back negative, this time I as prescribed me an antibiotic, albuterol inhaler and cough syrup with codeine. On February 8, 2023, I had a telehealth visit with my primary care physician who advised me to finish the medications I had been prescribed.
6 days after vaccination, a red sore rash appeared on my left arm, approx 3 inches below vaccination site.  Rash spread to an area of approximately 5? wide and 4? high and is swollen hot, itchy and uncomfortable and persists today, 10 days after vaccination. At the same time as the rash appeared I began to have sleepless nights, waking 2 hours after going to sleep every night and spending the rest of the night waking every hour. I had no symptoms, apart from a sore arm, until the 6 day point.
Information has been received from a health professional concerning a 20 year old female with no known drug allergies who on 08/24/2000 was vaccinated with a second dose in the right deltoid of varicella vaccine live. It was ntoed that on 07/25/2000 the pt was vaccinated with the first dose in the right deltoid of varicella vaccine live. On 10/17/2001 a titer was drawn and was found to be negative. Teh pt did not convert. It was also noted that on 06/19/2000 the pt received a second dose in the left deltoid of hep B vaccine recombinant. No further info was provided. Unspecified medical attention was sought.
Pt had red, raised , warm area 3" in diameter on left arm where immunization was given. Applied ice and mother gave Benadryl.
Cramping (gas?), chills, sweating, slightly faint, more than usual feces than normal during the night or in the morning, although NOT at all soft  like diarrhea. I didn't take my temp, but in the morning it was 97.6 F.  Lasted about 1 hour. I felt almost totally back to normal in 1.25 hours, and I felt great when I woke up 7-8 hours later.
pt recvd vax 4APR95 1130Am & pt awoke from nap 430PM, had an episode of excessive, prolonged crying;pt became pale & hypotonic (arms & legs limp & dangling);pt's eyes were open wide, staring & not blinking;episode lasted 2-3mins;fever
Diarrhea Weakness, decreased appetite, cannot smell or taste anything, had small amout of diarrhea. Narrative:
Patient gained out after a COVID 19 vacaine .  Pt regained concious briefly  after. 911 crew arrived a the scene  Patient BP & vital sign normal.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age.  On 28-JUN-2017 the patient was vaccinated with ZOSTAVAX lot # M035148, single dose for prophylaxis. On an unknown date in 2017, the patient experienced injection site pain and injection site discomfort. The outcome of injection site discomfort and injection site pain is unknown.      The causal relationship between the ZOSTAVAX and the events was not provided.
SLEEP DEPRAVED; DRY EYES; ACHE BEHIND THE EYES; CHILLS; SEVERE HEADACHE; MUSCLE ACHE; FATIGUE; This spontaneous report received from a patient concerned a 65 year old of unspecified sex. The patient's weight, height, and medical history were not reported .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN) .5 ml, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-MAR-2021, the subject experienced sleep depraved. On 07-MAR-2021, the subject experienced dry eyes. On 07-MAR-2021, the subject experienced ache behind the eyes. On 07-MAR-2021, the subject experienced chills. On 07-MAR-2021, the subject experienced severe headache. On 07-MAR-2021, the subject experienced muscle ache. On 07-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, severe headache, muscle ache, fatigue, sleep depraved, dry eyes and ache behind the eyes was not reported. This report was non-serious.
This spontaneous report was received from a medical assistant who administered vaccines refers to a patient of unknown age (gender unspecified). On 08-NOV-2012, the patient was vaccinated with a dose of ZOSTAVAX, (lot number, expiration date and route not provided) that was stored in the fridge at 6 degree celsius for 3 weeks (504 hours) and it was not a supported excursion. No concomitant medications were reported. The patient was not experiencing any known symptoms. Additional information has been requested.
received booster dose from a vial stored >30 days in refrigerator; Vaccine that was kept for more than 30 days in the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received booster dose from a vial stored >30 days in refrigerator) and PRODUCT STORAGE ERROR (Vaccine that was kept for more than 30 days in the refrigerator) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (received booster dose from a vial stored >30 days in refrigerator) and PRODUCT STORAGE ERROR (Vaccine that was kept for more than 30 days in the refrigerator). On 29-Jan-2022, EXPIRED PRODUCT ADMINISTERED (received booster dose from a vial stored >30 days in refrigerator) and PRODUCT STORAGE ERROR (Vaccine that was kept for more than 30 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   There was no information on previous doses for the patient. Date the vial was initially stored in the refrigerator was 29-Dec-21 and the vial did not undergo any temperature excursions.  No concomitant medications was reported. No treatment drug details was reported.   This case was linked to MOD-2022-467833 (Patient Link).
Left arm sore, warm to the touch, swollen and red, itchy, fever, chills, bruising. Taking Advil and Benadryl for the itching. Pt went to ER the gave her Prednizone, Claritin, and Pepcid for stomach reaction from other medications. Pt has a dr appt on 9/20/12.
PERIPHERAL NEUROPATHY CARDIOGENIC SHOCK 2/23/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Redness at injection site on Friday night, Sat it became firing red. Used over the counter BENADRYL lotion. Then started to feel sick, couldn't eat or drink. Finally went to ER after she felt heart palpitation. Dr at ER said it could be an adverse effect to the vaccine.
Dizziness.  Fall.  Blood Pressure Drop and stabilize within 15min.
Hyperlipidemia; First dose on : 18-Feb-2021 and second dose on : 1-Apr-2021; This spontaneous case was reported by a nurse and describes the occurrence of HYPERLIPIDAEMIA (Hyperlipidemia) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on : 18-Feb-2021 and second dose on : 1-Apr-2021) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 038K20A) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Bystolic (10mg tablet) until 12-Jun-2014. Past adverse reactions to the above products included No adverse event with Bystolic. Concurrent medical conditions included Drug allergy (Allergy to hydrochlorothazide), Drug allergy (Allergy to Norvasc), Drug allergy (Allergy to Percocet), Sulfonamide allergy (Allergic to sulfa), Hypertensive heart disease (Hypertensive heart disease without congestive heart failure) since 24-Feb-2020, Type 2 diabetes mellitus (Type 2 diabetes mellitus without complication) since 24-Feb-2020, Gastroesophageal reflux disease (Gastroesophageal reflux disease without esophagitis) since 08-Mar-2019, Overweight since 06-Mar-2018 and Anxiety since 08-Mar-2019.   On 18-Feb-2021 at 2:02 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Apr-2021 at 10:55 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 01-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on : 18-Feb-2021 and second dose on : 1-Apr-2021). On 08-Nov-2021, the patient experienced HYPERLIPIDAEMIA (Hyperlipidemia). At the time of the report, HYPERLIPIDAEMIA (Hyperlipidemia) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on : 18-Feb-2021 and second dose on : 1-Apr-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was provided.   This case was linked to MOD-2022-645684 (Patient Link).
A non-serious spontaneous report of positive flu strain B and fever was received from a health professional concerning a 61 month old female. Medical history and concomitant medications were not reported. On 24-Aug-2009 the patient received FLUMIST. On 27-Aug-2009, the patient tested positive for Flu B and had a temperature of 104 Fahrenheit. The outcome of the events flu strain B and fever was not reported.
Information has been received from a registered nurse and refers to unspecified patients of unknown ages and genders. There was no information about patient's concurrent conditions, medical history or concomitant medications. On multiple unknown dates, the patients were most likely vaccinated with a dose of improperly stored GARDASIL 9 lot # M020103 and expiration date of 15-FEB-2018, (route of administration and anatomical location were not reported) for prophylaxis, which was stored at a lowest recorded temperature of 32 Fahrenheit (0 Celsius) and a highest temperature of 36 Fahrenheit (2.2 Celsius) for 34 days, the entire 24 hours each day, and a lowest recorded temperature of 46F (7.7 Celsius) and a highest 77F (25 Celsius) for 24 hours. No previous temperature excursion was reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports from the same source. Additional information has been requested. Sender's Comments: US-009507513-1702USA002770: US-009507513-1702USA002768: US-009507513-1702USA002769.
Information has been received from an office manager concerning a 17 year old female who on 19-OCT-2007 was vaccinated with the first dose of GARDASIL, 0.5 ml, lot # 658563/1063U. There were no problems noted after the first dose. On 19-MAY-2008 after receiving the second dose of GARDASIL, 0.5 ml, lot # 659182/1757U, the patient fainted. It was reported that the patient sought medical attention in the office and recovered on 19-MAY-2008. Additional information has been requested.
within about six hours, I had itching in my arm at injection site.  Then the itching was in my armpit.  By the next morning or about 12 hours later my arm area/lymph node was swollen and sore.  By 36 hours later, the lymph node was extremely sore and I was in pain and the itching spread to my breast on the left side.
Experiencing right-side, upper shoulder/neck pain through the arm and shoulder blade almost like a pinched nerve.
@ 7PM on 10-JUN92 pt had unconsolable crying for 2 hrs then intermittently all noc; from 7PM to early AM had severe stomache ache, t104, weakness in legs;
Patient received the first dose on 4/01/21 then he received 2nd dose by mistake on 4/06/21- No reaction
vaccine was administered 4/18/2022 beyond use date was04/18/2022 exp date 5/31/2022
10 days p/vax site of inj became warm, red, indurated & 7-10 small vesicles devel @ inj site;5 days later satellite vesicles devel;
after 5 minutes i got vertigo and dizziness, then at my work place i was with headache and diarrea the whole afternoon my whole body was hurting me i took a tylenol and i was much better.
My daughter received her first Moderna booster for COVID-19 on 6/3/2022. On 7/27/2022, she tested positive on a home antigen test for COVID-19. During her bout with COVID-19, the only symptom she had was a mild fever, which was under 101 and lasted for 3-4 days. It was so mild that we did not even give her medicine for it.
Chills shortly after going to bed. Shivering through the night until after taking Advil.
On 9/28/02 right arm was red, swollen and sore at injection site and arm was difficult to lift for next 24 hours. Symptoms seemed to improve. patient advised to take Tylenol and apply ice packs to injection site and call if no improvement. Patient came into office 10/1/02; redness seemed to be spreading. Patient reported to us 10/1/02.) Treatment--Allegra 180mg daily for 2 weeks and Augmentin 875mg bid. Follow up if develops any breathlessness or severe symptoms.
This spontaneous report as received from a licensed practical nurse refers to six patients of unknown age and gender. The patients were vaccinated with RECOMBIVAX HB (lot #, expiry date, route and dose were not reported) that was exposed to 25 Fahrenheit for an unknown period of time on an unknown date. No concomitant medications were reported. No adverse symptoms reported. This is one of several reports received from the same reporter. Follow up information was received from the licensed practical nurse who confirmed that none of the patients complained of any adverse experiences after receiving the above vaccines that had been stored incorrectly. Additional information is not expected.
Pt started feeling pain all over and skin feeling very hot, felt nauseous. Also felt chills and had a fever that night. By time she reported symptoms already feeling better after taking TYLENOL COLD and FLU. Fever has gone away, contacted PCP.
Nausea, headache, vertigo, malaise, fatigue since injections. Pruritis, redness started 4/10 to left shoulder for 4 days.
Since the second dose I have had multiple cardiac/ respiratory issues. The respiratory issues seemed to have faded over the last few years however the cardiac issues are getting worse. I have had multiple stents of tachycardia after eating or just sitting down watching tv. I have also had multiple arrhythmia issues where my heart will flutter/ skip beats. They started of slowly and have progressively got worse. Around February of this year. 2023 I went into Afib with RVR. My heart rate got up to 300bpm and was cardioverted. At the time all of my labs were normal with no signs of cardiac issues. I proceeded to see a cardiologist and wore a heart monitor for two weeks as well as getting and echo. According to the cardiologist there are no signs of heart issues except some like arrhythmias ?that he claims is normal? and an EF rate of 53, to which seems low for a 32 year old. I now have an appointment set up with a cardiac electrophysiologist on oct 6th because the symptoms are getting worse. Any time I walk, eat, my heart rate jumps as high as 170 and starts to skip beats. And all of these issues happened after the second dose of the covid vaccine. No health issues prior.
bell's palsey; This case was reported by a physician via call center representative and described the occurrence of bell's palsy in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and Flu vaccine. On an unknown date, unknown after receiving Shingrix and Flu vaccine, the patient experienced bell's palsy (serious criteria GSK medically significant). On an unknown date, the outcome of the bell's palsy was unknown.   It was unknown if the reporter considered the bell's palsy to be related to Shingrix and Flu vaccine.  Additional details were provided as follows. The age at vaccination was not reported. The retired neurologist reported that his colleague retired gerontologist received first dose of Shingrix on an unknown date and experienced bell's palsey. The patient also received a flu shot on the same day as Shingrix, in the opposite arm. No further details were available.
Admission Date: 5/22/2022 Discharge Date: May 27, 2022  PRESENTING PROBLEM: Atrial fibrillation with rapid ventricular response Pneumonia due to COVID-19 virus   HOSPITAL COURSE: Patient is a 66 year old man with a history of HTN, HLD, Afib with RVR who presented to the ER due to worsening dyspnea and fatigue .Found to be in Afib with RVR requiring 4 l of oxygen . CXR was consistent with pulmonary edema with BNP 3600. He was started on IV lasix and cardiology was consulted. He underwent Cardioversion which helped with his AFib with RVR , ECHO showed preserved ejection fraction. He was started on short acting cardizem 60 q6 hours along with toprol XL . But due to significant drop in HRs to 40s , metoprolol was held and cardizem dose was changed to long acting cardizem 120 mg daily. Patient was able to go on room air with diuresis and his symptoms significantly improved. Plan is he will follow with cardiology as outpatient for titration of cardizem dose . He also was treated with decadron at the hospital as he was found to have positive COVID this hospitalization. Remdisivir was not given as he was outside the window.
Blurred vision, off balance, low blood pressure.  Sent to ER and was admitted to hospital.     Tested negative for Covid19 on 1/25/2021 at hospital.  Returned to community 1/26/2021 and was sent to the ER within hours of being back from hospital.      He remains at the hospital and will be returning on hospice.
Initial information received on 04-Oct-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 44 years old female patient who experienced swelling, redness at injection site, joint pain and limited mobility and hot to touch, while she received vaccine ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On an unknown date, the patient received a dose of suspect Diphtheria-2/Tetanus/5 AC Pertussis Vaccine (lot number not reported) via unknown route in the right arm. On 04-Oct-2018, the patient developed a non-serious swelling, redness at injection site (injection site erythema), joint pain (arthralgia) and limited mobility and hot to touch (mobility decreased) (latency unknown) following the administration of Diphtheria-2/Tetanus/5 AC Pertussis Vaccine. (Other relevant tests included No lab data.) Final diagnosis was limited mobility and hot to touch, joint pain, redness at injection site and swelling. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for swelling, as Unknown for redness at injection site, as Unknown for joint pain and as Unknown for limited mobility and hot to touch.
Patient admitted to the hospital due to a fall and COVID-19 symptoms (dizziness) 7/22/2022- 8/1/2022.  Medications included zinc 50mg PO daily, cholecalciferol 25mcg PO daily, ascorbic acid 1000mg PO daily.
Expired Vaccine administered; 1 Patient is having side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine administered) and VACCINATION COMPLICATION (1 Patient is having side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine administered) and VACCINATION COMPLICATION (1 Patient is having side effects). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine administered) had resolved and VACCINATION COMPLICATION (1 Patient is having side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.   This case was linked to MOD-2021-261682 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up received 27-JUL-2021, No new information On 10-Sep-2021: Follow-up document received contains No New Information.
Moderna COVID-19 Vaccine  Approximately 25-30 minutes after receiving the vaccine, I developed angioedema of the face, mouth, and tongue. I required epinephrine and diphenhydramine. Approximately 3.5hrs following the first dose of epinephrine / diphenhydramine, I had a rebound reaction and new dysphagia and went to the emergency department where I required another dose of epinephrine, IV famotadine, IV diphenhydramine, IV dexamethasone, and IV odanestron to bring the symptoms under control.   No local reaction at the injection site. Angioedema, urticaria, and dysphagia were all solely focused to the head, face, and mouth.
Patient experienced left arm redness, swelling and pain for about 3-4 days. Vomiting for 2 days.
after first shot, massive headache for 3 days, then deep bone aches that set in and were still going as of 7/8/2021.  the bone aches were so severe that they impacted walking and movement.  I was also extremely lethargic & was taking naps when I never do this.    in addition, fingers, feet and ankles swelled significantly.  this required treatment of steroids by rheumatologist.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was provided regarding the patient's past medical history, concurrent conditions, or concomitant medication. In 2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) for routine health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles, but rather caused the patient to contract a persistent strain of herpes zoster. Shortly after receiving ZOSTAVAX vaccine, the patient developed a painful rash accompanied by persistent pain. In response to these complaints, the patient presented to a physician and was diagnosed as suffering from shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX.  The outcome of the events was considered to be not recovered. Additional information has been requested.
Developed Herpes zoster. Pt was part of varicella exposure at work. Had (+) h/o varicella dz, negative titer. VARIVAX vaccine given pt. developed Herpes Zoster.
I started feeling poorly on 01/04/2022. I tried to schedule a COVID-19 test but couldn't get in until 01/06/2022. I had a lot of head congestion and postnasal drip like cough. I was also really fatigued to the point that going up the stairs winded me. On 01/06/2022, I tested positive for COVID-19. I was given an rx for cough medicine which helped (Benzonate) and allowed me to get some sleep. These symptoms lasted for about a week then resolved. By the time I got the COVID19 test results back, I was already getting better.